Related Experiment Videos
Therapeutic considerations for infections caused by Staphylococcus epidermidis
1Department of Pharmacy, College of Pharmacy, University of Illinois, Chicago 60612.
Pharmacotherapy
|January 1, 1988
Summary
Vancomycin is crucial for treating methicillin-resistant Staphylococcus epidermidis infections. Its importance in managing serious gram-positive infections is growing, even for surgical prophylaxis in specific cases.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Increasing incidence of methicillin-resistant Staphylococcus epidermidis (MRSE) infections globally.
- Vancomycin as a primary bactericidal agent against MRSE and other resistant gram-positive bacteria.
Purpose of the Study:
- To highlight the pivotal role of vancomycin in treating serious gram-positive infections.
- To discuss the evolving indications for vancomycin, including potential prophylactic use.
Main Methods:
- Literature review of current clinical practices and emerging infectious disease trends.
- Analysis of vancomycin's efficacy against resistant gram-positive pathogens.
Main Results:
- Vancomycin demonstrates reliable bactericidal activity against MRSE.
- It is the treatment of choice for MRSE and serious gram-positive infections in penicillin-allergic patients.
- Vancomycin is essential for treating central nervous system infections, endocarditis, meningitis, and septicemia.
Conclusions:
- Vancomycin's significance in managing gram-positive infections is increasing, irrespective of allergy or resistance.
- Routine surgical prophylaxis with vancomycin is generally not recommended, except in specific high-risk scenarios like implant surgery complications.